Literature DB >> 18820778

Heparin quality control in the Brazilian market: implications in the cardiovascular surgery.

Eduardo I Melo1, Mariana S Pereira, Rodrigo S Cunha, Mauro Paes Leme de Sá, Paulo A S Mourão.   

Abstract

INTRODUCTION: The change in the heparin solution trade mark in Brazil that had been commonly used in cardiac surgery has shown increased number in the coagulopathy, re-exploration and other side effects in our Institution and others.
METHODS: All four different heparin solutions available in the Brazilian market were studied in the Connective Tissue Lab, HUCFF, UFRJ and compared to the Liquemine (out of the market) and the international control solution. All samples were evaluated by magnetic nuclear resonance as well as their anticoagulant effectiveness.
RESULTS: There were significant differences among them regarding the anticoagulant activity. It was also observed contamination with other dermatan sulfate, samples chemically degraded and with significant change in the molecular weight.
CONCLUSION: Among the studied samples, none of them can offer security in cardiac surgeries on pump. None of them has demonstrated similar quality to Liquemine, which is not available in the Brazilian market.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820778     DOI: 10.1590/s0102-76382008000200004

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


  3 in total

1.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 2.  Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs.

Authors:  Paulo A S Mourão
Journal:  Mar Drugs       Date:  2015-05-06       Impact factor: 5.118

3.  Bovine and porcine heparins: different drugs with similar effects on human haemodialysis.

Authors:  Ana M F Tovar; Lisandra A C Teixeira; Simone M Rembold; Maurilo Leite; Jocemir R Lugon; Paulo A S Mourão
Journal:  BMC Res Notes       Date:  2013-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.